Taiwan FDA registration f5838b817ad90b73c7996225378d991a
Symoxir fibrinogen protein decomposition assay reagent
TW: 希摩西爾纖維蛋白原蛋白分解物測定試劑
Taiwan·Risk Class 2·BIOKIT S.A.·Registered Jan 08, 2018 – Jan 08, 2028ActiveRegistration details
- Analysis ID
- f5838b817ad90b73c7996225378d991a
- Customs Code
- DHA05603048202
Company information
- Manufacturer
- BIOKIT S.A.
- Manufacturer Country
- Spain
- Authorized Representative
- Werfen Taiwan Limited
Product details
- Intended Use
- ACL TOP family series instruments quantitatively determine the concentration of fibrinogen protein decomposition in human citrate acidified plasma.
- Product Type (Level 1)
- B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical); A.1150 calibration;; B.7320 Analysis of pro-fiber/fiber-based protein disintegration products
- Import Information
- import
Dates and status
- Registration Date
- Jan 08, 2018
- Expiry Date
- Jan 08, 2028
About this record
Access comprehensive regulatory information for Symoxir fibrinogen protein decomposition assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f5838b817ad90b73c7996225378d991a and manufactured by BIOKIT S.A.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices